These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15290005)

  • 21. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation.
    Galanopoulos A; Polissidis A; Georgiadou G; Papadopoulou-Daifoti Z; Nomikos GG; Pitsikas N; Antoniou K
    Pharmacol Biochem Behav; 2014 Sep; 124():58-66. PubMed ID: 24867078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca
    Qian WJ; Yin N; Gao F; Miao Y; Li Q; Li F; Sun XH; Yang XL; Wang Z
    Neuropharmacology; 2017 Sep; 124():143-156. PubMed ID: 28431968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
    Yu XH; Cao CQ; Martino G; Puma C; Morinville A; St-Onge S; Lessard É; Perkins MN; Laird JMA
    Pain; 2010 Nov; 151(2):337-344. PubMed ID: 20696525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
    Pattij T; Janssen MC; Schepers I; González-Cuevas G; de Vries TJ; Schoffelmeer AN
    Psychopharmacology (Berl); 2007 Jul; 193(1):85-96. PubMed ID: 17387457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
    Cagni P; Barros M
    Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid 1 (CB1) receptor mediates WIN55, 212-2 induced hypothermia and improved survival in a rat post-cardiac arrest model.
    Weng Y; Sun S; Park J; Ye S; Weil MH; Tang W
    Resuscitation; 2012 Sep; 83(9):1145-51. PubMed ID: 22289684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
    Schneider M; Drews E; Koch M
    Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
    Guo J; Ikeda SR
    Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.
    Pozzi O; Misiano P; Clark GD; Visentin L
    Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat.
    Bereiter DA; Bereiter DF; Hirata H
    Pain; 2002 Oct; 99(3):547-556. PubMed ID: 12406531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.
    Clarke JR; Rossato JI; Monteiro S; Bevilaqua LR; Izquierdo I; Cammarota M
    Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.